Clinical Trial

Sequential bpMRI for Suspicious Prostate Lesions

Study acronym: SEQ-bpMRI
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
This study aims to establish a prospective exploratory cohort and database to observe the dynamic evolution of bi-parametric MRI (bpMRI). Investigators intend to study the clinical utility of sequential MRI combined with prostate biopsy in the diagnosis of prostate cancer. Specifically, by utilizing bpMRI findings and their dynamic changes to guide the timing of biopsies, investigators aim to avoid unnecessary procedures. Furthermore, the safety and efficacy of this strategy will be assessed through long-term follow-up, ultimately promoting the precision diagnosis and treatment of prostate cancer.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-12-30.
Trial Details
NCT Number NCT07332832
Lead Sponsor Peking University First Hospital
Collaborators: Shanghai East Hospital of Tongji University
Conditions Prostate Cancer
Enrollment 1,000 participants
Start Date 2026-02-01
Primary Completion 2028-12-31 (estimated)
Study Completion 2029-05-31 (estimated)
Updated on ClinicalTrials.gov 2026-02-18